Daix, Thomas
Mathonnet, Armelle
Brakenridge, Scott
Dequin, Pierre-François
Mira, Jean-Paul
Berbille, Frederique
Morre, Michel
Jeannet, Robin
Blood, Teresa
Unsinger, Jacqueline
Blood, Jane
Walton, Andrew
Moldawer, Lyle L.
Hotchkiss, Richard
François, Bruno http://orcid.org/0000-0002-2531-1652
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
https://doi.org/10.1186/s13613-023-01109-w
Article History
Received: 10 October 2022
Accepted: 7 February 2023
First Online: 12 March 2023
Declarations
:
: The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and the International Council for Harmonization Guidance for Good Clinical Practice, and was approved by the relevant local French and American ethics committees. All subjects/legally acceptable representatives provided written informed consent.
: Not applicable.
: FB and MM are RevImmune employees. The other authors declare no competing interests.